Ribomic
4591.TPharmaceutical
Major holders (5%+) · 1
| Holder | Stake |
|---|---|
| Evo Fund | 28.68% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 2
| SMBC Nikko Securities Inc. | 2.81% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 41
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2026-04-21 · amended | 0.00% | no change |
| Evo Fund2026-04-21 · amended | 30.79% | +2.11pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 28.68% | -0.61pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 29.29% | -1.06pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 30.35% | -0.48pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 30.83% | -1.30pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 32.13% | -0.27pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 32.40% | -1.42pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 33.82% | -0.76pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 34.58% | -1.12pp |
| Evolution Capital Management LLC2025-08-18 · amended | 0.00% | no change |
| Evo Fund2025-08-18 · amended | 35.70% | -1.28pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.